MBX Biosciences, Inc. Common Stock (NASDAQ: MBX) is a Healthcare company (Biotechnology) with a market capitalization of $2.6B. The Maz Rating grades it against the other companies in its sector.
MBX Biosciences, Inc. Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $53.10, MBX Biosciences, Inc. Common Stock trades at 5.4x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -34.4%, return on invested capital of -33.7% and a free cash flow yield of -3.8%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 19.58. Over the past 52 weeks the share price ranged from $25.11 to $72.64, with a beta of 0.10.
MBX Biosciences, Inc. Common Stock does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 7 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.